Allurar rigakafin Hepatitis A da B

Ana amfani da rigakafin Hepatitis A da B domin samar da kariya daga Hepatitis A da Hepatitis B. Ana ba da shi ta hanyar allura a cikin tsoka.

Ana amfani da shi a yankunan da cutar hepatitis A da B ke da iyaka, ga matafiya, mutanen da ke fama da cutar Hepatitis C ko cutar hanta mai tsanani, da waɗanda ke cikin haɗarin cututtukan da ake samu ta hanyar jima'i.

Allurar rigakafin da aka haɗu tana da aminci da kariya kamar dai an ba ta a matsayin allurar rigakafi ta hepatitis A da B. Gabaɗaya ana jurewa sosai. Sakamakon cututtuka na yau da kullun suna da sauƙi kuma sun haɗa da ja da ciwo a wurin allurar, inda karamin kumfa zai iya bayyana. Jin rauni ko gajiya, ko ciwon kai na iya faruwa. Sauran sakamako masu illa sun haɗa da rashin ƙarfi, ƙanƙara, rash, rauni, zubar da jini mara kyau kamar daga hanci ko gemu, rauni tsoka ko ciwo. Sakamakon cututtuka masu tsanani ba su da yawa kuma sun haɗa da rashin lafiyan da fashewa.

Yana samuwa a ko'ina.

 Tsarin gudanarwa 
Ana gudanar da allurar rigakafin Twinrix ta yau da kullun ta hanyar allurar intramuscular a yankin deltoid ta amfani da jadawalin allurai daban-daban guda uku a 0, 1, da watanni 6 ([ƙananan lokaci: makonni 4 tsakanin allurai 1 da 2, watanni 5 tsakanin allurai 2 da 3]). A wasu yanayi, ana iya amfani da jadawalin hanzarin sashi na 0, 7 da 21 zuwa 30 kwanaki sannan kuma ana nuna cewa yana da irin wannan inganci kamar jadawalin gargajiya.

 Tasiri 
Cibiyoyin Kula da Cututtuka da Rigakafin Cututtuka na Amurka (CDC) sun ba da rahoton cewa gwaje-gwajen asibiti sun sami matakan kariya daga Hepatitis A da Hepatitis B wata daya bayan kowane sashi:

 A: 93.8%, 98.8%, 99.9%
 B: 30.8%, 78.2%, 98.5%

 Samun sa 
Twinrix alama ce da GlaxoSmithKline Biologicals ta ƙera. Cikakken sunan shine allurar rigakafin Hepatitis A da ba a aiki ba da kuma allurar rigakawa ta Hepatitis B (recombinant). Ana ba da Twinrix a kan allurai uku. An kirkiro sunan ne saboda cakuda ne na allurar rigakafi biyu da suka gabata - Havrix, allurar rigar Hepatitis A da ba ta aiki ba, da Engerix-B, allurar Allurar rigakafin Hepatitis B.  Twinrix ya fara shiga kasuwa a farkon shekara ta 1997.

A Amurka, Hukumar Abinci da Magunguna (FDA) ta amince da Twinrix ga waɗanda suka kai shekaru 18 da haihuwa. A wasu ƙasashe a waje da Amurka, musamman Kanada da Tarayyar Turai, an san Twinrix da Twinrix Adult ko Ambirix kuma tsarin ilimin yara, wanda ake kira Twinrix Junior ko Twinrix Paediatric, yana samuwa..   [<span title="This claim has too many footnotes for reading to be smooth. (January 2021)">excessive citations</span>]

 Al'umma da al'adu 

 Tattalin Arziki 
Ta hanyar kasancewa haɗuwa yana iya rage farashin gudanarwa kuma ya sami ingantaccen maganin rigakafin.

 Sunayen alama 
Sunayen alama sun haɗa da Twinrix, Twinrix Junior, Twinrix paediatric, Ambirix, da Bilive.

 Manazarta 

Rukuni:Maganin ciwon hanta